232 related articles for article (PubMed ID: 17908631)
1. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
Aleman BM; van Leeuwen FE
Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
[TBL] [Abstract][Full Text] [Related]
2. Late complications of therapy of Hodgkin's disease: prevention and management.
Ng AK; Mauch PM
Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846
[TBL] [Abstract][Full Text] [Related]
3. Late effects of Hodgkin's disease and its treatment.
Ng AK; Mauch PM
Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?
van der Maazen RW; Raemaekers JM
Curr Opin Oncol; 2006 Nov; 18(6):660-6. PubMed ID: 16988591
[TBL] [Abstract][Full Text] [Related]
5. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials.
Bar Ad V; Paltiel O; Glatstein E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1472-9. PubMed ID: 19028275
[TBL] [Abstract][Full Text] [Related]
7. [Late complications of treatment for Hodgkin's disease in children and adolescents].
Balwierz W; Moryl-Bujakowska A
Przegl Lek; 2006; 63(1):31-6. PubMed ID: 16892897
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
Goodman KA; Riedel E; Serrano V; Gulati S; Moskowitz CH; Yahalom J
J Clin Oncol; 2008 Nov; 26(32):5240-7. PubMed ID: 18809615
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma in Tyrol-a population-based study.
Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin lymphoma as second malignancy during continuing chemotherapy for childhood acute lymphoblastic leukemia.
Alebouyeh M; Moussavi F; Haddad-Deylami H; Vossough P
Klin Padiatr; 2008; 220(6):388-90. PubMed ID: 18949677
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin lymphoma: the follow-up of long-term survivors.
Hodgson DC
Hematol Oncol Clin North Am; 2008 Apr; 22(2):233-44, vi. PubMed ID: 18395147
[TBL] [Abstract][Full Text] [Related]
12. [Hodgkin's Lymphoma].
Drouet F; Cahu X; Pointreau Y; Denis F; Mahé MA
Cancer Radiother; 2010 Nov; 14 Suppl 1():S198-209. PubMed ID: 21129664
[TBL] [Abstract][Full Text] [Related]
13. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
15. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
16. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
17. [Late treatment related complications of Hodgkin's disease].
Henry-Amar M; Gisselbrecht C
Rev Prat; 1998 May; 48(10):1092-7. PubMed ID: 9781154
[TBL] [Abstract][Full Text] [Related]
18. Late complications of Hodgkin's disease management.
Young RC; Bookman MA; Longo DL
J Natl Cancer Inst Monogr; 1990; (10):55-60. PubMed ID: 2189477
[TBL] [Abstract][Full Text] [Related]
19. Long-term complications of lymphoma and its treatment.
Ng AK; LaCasce A; Travis LB
J Clin Oncol; 2011 May; 29(14):1885-92. PubMed ID: 21483015
[TBL] [Abstract][Full Text] [Related]
20. Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies.
Schellong G; Riepenhausen M
Klin Padiatr; 2004; 216(6):364-9. PubMed ID: 15565552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]